Dade International Inc. and TOA Medical Electronics Co. Ltd. Agree in Principle to Form a Global Hemostasis Alliance.DEERFIELD, Ill.--(HealthWire)--Feb. 6, 1995--Dade International Inc. and TOA TOA Trials of Atlantis (game) TOA Time Of Arrival TOA Top of the Atmosphere TOA Transfer Of Authority TOA Table of Authorities (legal documents) TOA Terms Of Agreement TOA Transfer of Assets Medical Electronics Co. Ltd., Kobe, Japan have signed a letter of intent agreeing in principle to a multi-year global alliance for distribution of their complementary hemostasis hemostasis /he·mo·sta·sis/ (he?mo-sta´sis) (he-mos´tah-sis) 1. the arrest of bleeding by the physiological properties of vasoconstriction and coagulation or by surgical means. 2. product lines. When completed, the alliance will bring together the world's leader in hemostasis reagents and controls with the leading developer of clinical diagnostic instrument systems and will provide the parties with the ability to offer an integrated hemostasis product range worldwide. The global hemostasis market totals $500 million in annual sales of instrumentation, reagents and control materials. Hemostasis is the science of measuring the clotting capabilities of a patient's blood. Testing is ordered for identification of pre-surgical bleeding and diagnosis of hemostatic hemostatic /he·mo·stat·ic/ (he?mo-stat´ik) 1. causing hemostasis, or an agent that so acts. 2. due to or characterized by stasis of the blood. he·mo·stat·ic adj. blood disorders blood disorders, n.pl hematologic dyscrasias that affect the component cells and plasma elements of the blood. They are generally divided into two broad groups: those in which an increase in bulk occurs (e.g. , and for monitoring anti-coagulant medication therapy. Under the global alliance, Dade International or TOA Medical Electronics, depending on the territory, will undertake the marketing, distribution, sales and service responsibility for the total line of hemostasis products. The reagents and control materials will be marketed under the "Dade" brand name of Dade International, and the instruments will be marketed under the "Sysmex" brand name of TOA Medical Electronics. Dade International will be responsible for marketing, distribution and sales of the total line of hemostasis products in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. beginning July 1, 1995. Dade International will continue its exclusive distribution relationship with Baxter Healthcare Corp. including the complete hemostasis product line. TOA Medical Electronics, through its wholly owned U.S. subsidiary, Sysmex Corp., will continue to market directly its hematology systems, with continued exclusive distribution of reagents and supplies through Baxter Healthcare Corp. "Dade International has always held TOA Medical Electronics in high regard," said Scott Garrett E. Scott Garrett (born July 9, 1959 in Englewood, New Jersey) is a member of the United States House of Representatives. He is a Republican and has represented New Jersey's Fifth Congressional District seat since January 2003 (map). , president and chief executive officer of Dade International. "We look forward to a long and collaborative relationship which will strengthen our hemostasis technology, reagents and customer relationships by providing us with the complementary instrumentation skills of TOA." Dade International owns and operates the worldwide in-vitro diagnostics manufacturing and service businesses recently acquired by Bain Capital Bain Capital LLC is a Boston, Massachusetts-based private equity firm founded in 1984 by Mitt Romney, the former Governor of Massachusetts, and two other partners from the consulting firm Bain & Company: T. Coleman Andrews III and Eric Kriss. from Baxter International Baxter International Inc. (NYSE: BAX), is a global healthcare company with 48,000 employees and 2006 sales of US$10.4 billion. Its headquarters is in Deerfield, Illinois. Inc., and concentrates on the development and manufacture of hemostasis reagents, quality control materials, and automated microbiology, chemistry and immunochemistry Immunochemistry A discipline concerned both with the structure of antibody (immunoglobulin) molecules and with their ability to bind an apparently limitless number of diverse chemical structures (antigens); with the structure, organization, and rearrangement systems. Dade International sales in 1994 exceeded $600 million worldwide. TOA Medical Electronics, through its subsidiary companies such as Sysmex Corp., is a leading international manufacturer and marketer of clinical diagnostic instrument systems. TOA Medical Electronics focuses on the development and manufacture of hematology, hemostasis, urinalysis, and immunochemistry instrument systems. With the Sysmex brand of hematology systems, TOA Medical Electronics holds a leading position in this billion dollar global market. CONTACT: Dade International Inc. Carl Apfelbach, 708/267-5460 or Dana Anton, 708/267-5423 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion